NAS:PRAH (USA) Also trade in: Germany

PRA Health Sciences Inc

$ 99.48 0.16 (0.16%)
Volume: 389,344 Avg Vol (1m): 595,516
Market Cap $: 6.53 Bil Enterprise Value $: 7.44 Bil
P/E (TTM): 41.65 P/B: 5.98
Earnings Power Value 11.34
Net Current Asset Value -22.01
Tangible Book -16.16
Projected FCF 38.25
Median P/S Value 89.15
Graham Number 0
Peter Lynch Value 59.75
DCF (FCF Based) 0
DCF (Earnings Based) 0
1Y (-%)

PRAH News and Headlines - PRA Health Sciences

GuruFocus Articles Total 27
  • 1
  • 2

RALEIGH, N.C., July 11, 2019 (GLOBE NEWSWIRE) -- In a release issued under the same headline on July 9, 2019 by PRA Health Sciences, Inc. ( PRAH), please note that in the second paragraph of the release, the conference call ID and replay ID should read "6295812" and not "1876878" as previously stated. The corrected release follows:

PRA Health Sciences, Inc. ( PRAH) will release its second quarter 2019 results after the market closes on Wednesday, July 31, 2019. The Company will also host a conference call on Thursday, August

0 Views    Marketwired    2019-07-11 16:07

RALEIGH, N.C., July 09, 2019 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. ( PRAH) will release its second quarter 2019 results after the market closes on Wednesday, July 31, 2019. The Company will also host a conference call on Thursday, August 1, 2019 at 9:00 a.m. (ET) to discuss the results with members of the investment community.

To participate via telephone, investors and analysts should dial (877) 930-8062 within the United States or (253) 336-7647 outside the United States approximately 10 minutes prior to the call start time.

0 Views    Marketwired    2019-07-10 00:05

RALEIGH, N.C., May 14, 2019 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. is pleased to announce it has received an array of awards and recognition during the first months of 2019.

On Saturday, May 4, PRA was recognized as the Clinical Research Company of the Year – the Americas by PharmaTimes. This is the seventh consecutive year that the company has won this prestigious industry award.

Clinical Researcher of the Year – The Americas is a real-world competition that recognizes the talent and passion of industry and academic researchers and is considered a key barometer

0 Views    Marketwired    2019-05-14 12:01

RALEIGH, N.C., April 09, 2019 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. ( PRAH) will release its first quarter 2019 results after the market closes on Wednesday, May 1, 2019. The Company will also host a conference call on Thursday, May 2, 2019 at 9:00 a.m. (ET) to discuss the results with members of the investment community.

To participate via telephone, investors and analysts should dial (877) 930-8062 within the United States or (253) 336-7647 outside the United States approximately 10 minutes prior to the call start time.

0 Views    Marketwired    2019-04-09 20:00

RALEIGH, N.C., April 08, 2019 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. is pleased to announce it has won a 2019 CRO Leadership Award in the following categories:

  • Capabilities (Overall, Big Pharma, Small Pharma)
  • Compatibility (Overall, Big Pharma, Small Pharma)
  • Expertise (Small Pharma)
  • Quality (Small Pharma)
  • Reliability (Small Pharma)

The CRO Leadership Awards were developed in 2012 by Life Science Leader, a business journal for executives in emerging biotech through big pharma, to support the time-consuming and complex vetting process for selecting outsourcing partners. For

0 Views    Marketwired    2019-04-08 16:01

BLUE BELL, Pa., March 07, 2019 (GLOBE NEWSWIRE) -- PRA Health Sciences is delighted to be included as the only CRO on the Philadelphia Inquirer’s list of Top Workplaces for 2019. 

The best employers around the country are annually recognized for their commitment to developing and sustaining a culture that supports, promotes, and values its employees with the Top Workplaces Award. This year, Philadelphia Inquirer partnered with Energage, a research company that administers online surveys to employees, to honor the companies nominated in the Greater Philadelphia area.

0 Views    Marketwired    2019-03-07 21:01

RALEIGH, N.C, Feb. 25, 2019 (GLOBE NEWSWIRE) -- PRA Health Sciences and the non-profit Center for Information and Study on Clinical Research Participation (CISCRP) are pleased to announce that they are collaborating to prepare and deliver Trial Results Summaries to study volunteers. A key focus for PRA is to provide a more positive overall experience for both patients and families throughout the clinical trial process. Keeping patients informed and engaged with meaningful information through this unique collaboration will help achieve that goal.

Trial Results Summaries — also

0 Views    Marketwired    2019-02-25 17:13

NEW YORK, Feb. 06, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Conagra Brands Inc. (:CAG), National Retail Properties (:NNN), PRA Health Sciences, Inc. (PRAH), Westinghouse Air Brake Technologies Corporation (:WAB), YRC Worldwide, Inc. (YRCW), and Infinity Pharmaceuticals, Inc. (INFI), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to

0 Views    Marketwired    2019-02-06 13:02

RALEIGH, N.C., Feb. 04, 2019 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. ( PRAH) will release its fourth quarter and year end 2018 results after the market closes on Wednesday, February 27, 2019. The Company will also host a conference call on Thursday, February 28, 2019 at 9:00 a.m. (ET) to discuss the results with members of the investment community.

To participate via telephone, investors and analysts should dial (877) 930-8062 within the United States or (253) 336-7647 outside the United States approximately 10 minutes prior to the

0 Views    Marketwired    2019-02-05 01:00

FREMONT, Calif., Jan. 16, 2019 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (ZSAN) (“Zosano” or the “Company”), a clinical-stage biopharmaceutical company, today announced the appointment of Linda Grais, M.D., J.D. to its board of directors.

Dr. Grais brings a diverse and important set of experience and expertise to Zosano. After graduation from Yale Medical School and residency at UCSF, she was an assistant professor at UCSF in internal medicine, received her J.D. from Stanford Law School where she was an editor of Stanford Law and Policy Review before

0 Views    Marketwired    2019-01-16 17:02

Program data provides comprehensive measurement of large-scale 340B transaction activity across outlets

BLUE BELL, Pa., Dec. 13, 2018 (GLOBE NEWSWIRE) -- Symphony Health, a PRA Health Sciences company and a leading provider of data, cloud-based analytics and consulting solutions to life science companies and healthcare organizations, today announces the availability of 340B Drug Discount Program data. This data may be integrated directly into the company’s PHAST® NonRetail Weekly and Monthly audits as well as NonRetailSource®, a comprehensive offering incorporating indirect and direct

0 Views    Marketwired    2018-12-13 17:04

RALEIGH, N.C., Nov. 27, 2018 (GLOBE NEWSWIRE) -- PRA Health Sciences (PRA) is pleased to announce the launch of its new Pediatric Site Network (PSN). PSN is a series of key pediatric research centers around the world which will allow PRA to improve pediatric clinical development and enhance access to novel medicines for the pediatric population. PRA has formalized relationships with centers in the EU, U.S. and Israel, with plans to expand to Latin America and Asia Pacific.

PRA’s Center for Pediatric Clinical Development, with its highly

0 Views    Marketwired    2018-11-27 17:02

NEW YORK, Nov. 06, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of PRA Health Sciences, Inc. (PRAH), Newmont Mining Corporation (:NEM), Hyster-Yale Materials Handling, Inc. (:HY), MGP Ingredients, Inc. (MGPI), Noble Midstream Partners LP (:NBLX), and Principal Financial Group, Inc. (PFG), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to

0 Views    Marketwired    2018-11-06 17:02

NEW YORK, Oct. 15, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Lancaster Colony Corporation (LANC), Pioneer Natural Resources Company (:PXD), Essex Property Trust, Inc. (:ESS), PRA Health Sciences, Inc. (PRAH), Pinnacle Entertainment, Inc. (PNK), and Laredo Petroleum, Inc. (:LPI), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers

0 Views    Marketwired    2018-10-15 12:01

RALEIGH, N.C., Sept. 25, 2018 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. ( PRAH) will release its third quarter results after the market closes on Wednesday, October 31, 2018. The Company will also host a conference call on Thursday, November 1, 2018 at 9:00 a.m. (ET) to discuss the results with members of the investment community.

To participate via telephone, investors and analysts should dial (877) 930-8062 within the United States or (253) 336-7647 outside the United States approximately 10 minutes prior to the call start time. The

0 Views    Marketwired    2018-09-26 00:00

RALEIGH, N.C., Aug. 06, 2018 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (the “Company”) (NASDAQ: PRAH) today announced that an affiliate of, or a fund sponsored by, Kohlberg Kravis Roberts & Co. (the “Selling Stockholder”), intends to offer for sale in an underwritten secondary offering 6,500,000 shares of common stock of the Company pursuant to the Company’s shelf registration statement filed with the Securities and Exchange Commission. The Selling Stockholder will receive all of the proceeds from this offering. No shares are being sold by the Company. The last

0 Views    GlobeNewswire    2018-08-06 22:00

RALEIGH, N.C., July 12, 2018 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (PRAH) will release its second quarter results after the market closes on Wednesday, August 1, 2018. The Company will also host a conference call on Thursday, August 2, 2018 at 9:00 a.m. (ET) to discuss the results with members of the investment community.

To participate via telephone, investors and analysts should dial (877) 930-8062 within the United States or (253) 336-7647 outside the United States approximately 10 minutes prior to the call start time. The

0 Views    Marketwired    2018-07-12 20:01

RALEIGH, N.C., May 24, 2018 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (PRAH) is pleased to announce it was recognized by PharmaTimes as the International Clinical Research Company of the Year. This is the fifth year in a row that PRA has received this award.

“This award celebrates excellence in the clinical research industry and we are honored to once again be recognized by our peers,” said Colin Shannon, President and Chief Executive Officer. “This award is possible thanks to the incredibly talented PRA

0 Views    Marketwired    2018-05-24 08:01

RALEIGH, N.C., May 03, 2018 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (PRAH) is pleased to announce it was recognized as the Clinical Research Company of the Year—Americas by PharmaTimes. PRA received the award at a ceremony in Washington, DC. The company has won this award consecutively since 2012.

“We are honored to once again receive this award,” said Michael Brooks, Executive Vice President, Product Registration, Americas. “It is a direct reflection of our incredibly talented team and the professionalism and passion that they

0 Views    Marketwired    2018-05-03 16:03

RALEIGH, N.C., April 25, 2018 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (PRAH) today announced that Linda Baddour, Executive Vice President and Chief Financial Officer will retire from her position as CFO, effective May 1, 2018.  Ms. Baddour will remain as Executive Vice President of the Company through September 30, 2018, to assist with the transition of her responsibilities and act as a special advisor to the Chairman and Chief Executive Officer.

In addition, the Company announced that Michael J. Bonello has been appointed by the

0 Views    Marketwired    2018-04-26 00:01

Headlines Total 112
  • 1
  • 2

2019-07-11 $97.49 (0.62%)
11:07am
2019-07-09 $97.1 (0.33%)
7:05pm
2019-06-17 $96.45 (0.54%)
8:11am
2019-05-31 $86.73 (-0.64%)
8:31am
2019-05-14 $88.1 (-1.21%)
7:01am
2019-05-12
7:46pm
2019-05-04
9:39pm
2019-05-03 $93.38 (1.5%)
4:34pm
9:15am
5:55am
2019-05-01 $95.24 (-1.63%)
5:45pm
2019-04-24 $95.51 (-0.44%)
11:14am
9:33am
2019-04-22 $94.3 (-0.18%)
10:33am
2019-04-21
1:04pm
2019-04-18 $94.47 (0.36%)
9:30am
2019-04-12 $101.61 (-2.11%)
10:52am
2019-04-09 $105.54 (-1.56%)
3:00pm
7:15am
2019-04-08 $107.21 (-0.16%)
11:01am
2019-04-04 $107.5 (-3.17%)
8:35am
8:30am
2019-04-02 $110.77 (-0.18%)
9:27am
2019-04-01 $110.97 (0.62%)
7:45am
2019-03-29 $110.29 (1.92%)
8:30am
2019-03-20 $107.72 (-1.57%)
10:05am
2019-03-19 $109.44 (2.56%)
8:30am
2019-03-15 $104.79 (0.88%)
8:17am
7:45am
2019-03-07 $101.98 (-1.86%)
3:01pm
2019-03-05 $107.89 (-0.63%)
6:37am
2019-02-28 $106.98 (-4.18%)
6:54pm
1:42pm
8:11am
2019-02-25 $113.37 (-0.67%)
11:13am
2019-02-20 $113.9 (0.18%)
9:31am
2019-02-04 $108.45 (1.06%)
7:00pm
2019-01-07 $91.41 (3.77%)
8:30am
2018-12-24 $84.24 (-3.67%)
10:17am
2018-12-13 $103.51 (-2.2%)
11:03am
8:30am
2018-12-06 $106.34 (-4.02%)
8:37pm
2018-12-04 $110.79 (-4.58%)
11:56am
11:51am
2018-11-30 $116.74 (2.51%)
8:31am
8:15am
8:15am
2018-11-28 $111.46 (6.12%)
7:51am
2018-11-27 $105.03 (0.99%)
11:02am
2018-11-22 $98.23 (%)
8:30am
2018-11-16 $100.6 (-0.85%)
8:02am
2018-11-06 $104.25 (1.72%)
11:02am
2018-11-05 $102.49 (1.99%)
1:03pm
8:20am
2018-11-02 $100.49 (1.26%)
8:15am
2018-11-01 $99.24 (2.45%)
5:40pm
2018-10-31 $96.87 (2.37%)
6:50pm
8:30am
2018-10-30 $94.63 (-0.28%)
10:52am
2018-10-24 $91.73 (-7.98%)
9:32am
2018-09-25 $109.17 (0.67%)
7:00pm
2018-09-24 $108.44 (0.61%)
9:02am
2018-09-06 $105.92 (-1.18%)
8:15am
2018-08-30 $105.01 (-0.59%)
8:22am
2018-08-27 $106.44 (0.99%)
1:00pm
7:43am
2018-08-24 $105.4 (0.89%)
8:34am
8:29am
2018-08-13 $101.05 (-0.36%)
8:15am
2018-08-04
9:59am
2018-08-02 $105.05 (0.22%)
1:01pm
9:58am
7:34am
2018-07-31 $105.14 (2.36%)
8:26am
8:21am
2018-07-30 $102.72 (-3.93%)
11:08am
2018-07-12 $99.48 (1.63%)
3:01pm
2018-07-11 $97.88 (0.11%)
2:58pm
8:46am
2018-07-10 $97.77 (1.27%)
1:37pm
2018-06-26 $93.49 (-0.8%)
10:00am
2018-06-01 $84.74 (-0.19%)
7:53am
2018-05-24 $80.89 (-0.65%)
3:00am
2018-05-07 $81.19 (-3%)
2:08pm
2018-05-03 $82.46 (1.02%)
11:03am
2018-04-26 $81.61 (-3.72%)
2:51pm
2018-04-25 $84.76 (-0.59%)
7:01pm
2018-04-24 $85.26 (-2.35%)
8:08am
2018-04-23 $87.31 (0.05%)
9:38am
2018-04-12 $86.41 (1.61%)
7:00pm
2018-02-22 $82.99 (-6.74%)
10:15am
2017-12-27 $91.35 (0.23%)
8:43am
2017-12-26 $91.14 (-0.43%)
9:14am
2017-12-20 $90.79 (-0.59%)
11:30am
2017-12-11 $83.75 (1.26%)
9:13am
2017-12-07 $81.6 (0.17%)
8:26am
2017-12-06 $81.46 (0.57%)
12:07pm
7:43am
2017-12-05 $81 (0.62%)
7:52am
2017-12-01 $81.85 (0.65%)
7:42am
Total 112
  • 1
  • 2